NS-626

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNS-626
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsPsychotic DisordersCraniocerebral TraumaAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch As
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersCraniocerebral TraumaAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A